Chloroquine Resistance in Plasmodium vivax

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2004-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.48.11.4075-4083.2004PMID 15504824PMCID PMC525399
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drugs for parasitic infections.

  2015cited by this paper
• The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects

  2004cited by this paper
• Primaquine therapy for malaria.

  2004cited by this paper
• Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine.

  2004cited by this paper
• 96 Vivax malaria resistant to treatment and prophylaxis with chloroquine

  2003influential reference
• Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua.

  2003cited by this paper
• Correlation between Plasmodium vivax variants in Belém, Pará State, Brazil and symptoms and clearance of parasitaemia.

  2003cited by this paper
• Simple In Vitro Assay for Determining the Sensitivity of Plasmodium vivax Isolates from Fresh Human Blood to Antimalarials in Areas where P. vivax Is Endemic

  2003cited by this paper
• Toxicity Related to Chloroquine Treatment of Resistant Vivax Malaria

  2003cited by this paper
• Single-nucleotide polymorphisms and genome diversity in Plasmodium vivax

  2003cited by this paper
• Chloroquine-resistant Plasmodium vivax malaria in Peru.

  2003cited by this paper
• Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.

  2002cited by this paper
• An in vitro system for assessing the sensitivity of Plasmodium vivax to chloroquine.

  2002cited by this paper
• Short report: therapeutic efficacy of chloroquine combined with primaquine against Plasmodium falciparum in northeastern Papua, Indonesia.

  2002cited by this paper
• Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam *

  2002cited by this paper
• Assessment of therapeutic response of Plasmodium vivax and Plasmodium falciparum to chloroquine in a Malaria transmission free area in Colombia.

  2002cited by this paper
• Sensitivity of Plasmodium vivax to chloroquine in Sa Kaeo Province, Thailand.

  2002influential reference
• Chloroquine for the treatment of uncomplicated malaria in Guyana

  2002cited by this paper
• Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax

  2002cited by this paper
• Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia

  2002cited by this paper
• The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia

  2002cited by this paper
• Plasmodium vivax malaria in Southeast Iran in 1999-2001: establishing the response to chloroquine in vitro and in vivo.

  2002cited by this paper
• Drug resistant falciparum malaria: clinical consequences and strategies for prevention.

  2001cited by this paper
• Med J Malaysia

  2001cited by this paper
• Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria.

  2001cited by this paper
• Plasmodium vivax clinically resistant to chloroquine in Colombia.

  2001cited by this paper
• Chloroquine-resistant malaria.

  2001cited by this paper
• Chloroquine/doxycycline combination versus chloroquine alone, and doxycycline alone for the treatment of Plasmodium falciparum and Plasmodium vivax malaria in northeastern Irian Jaya, Indonesia.

  2001cited by this paper
• The neglected burden of Plasmodium vivax malaria.

  2001cited by this paper
• Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum.

  2000cited by this paper
• Adaptation of a chloroquine-resistant strain of Plasmodium vivax from Indonesia to New World monkeys.

  2000cited by this paper
• In-vivo sensitivity of Plasmodium vivax isolates from Rondônia (western Amazon region, Brazil) to regimens including chloroquine and primaquine

  2000cited by this paper
• Canadian recommendations for the prevention and treatment of malaria among international travellers. Committee to Advise on Tropical Medicine and Travel CATMAT), Laboratory for Disease Control.

  2000cited by this paper
• An unusual case of multidrug-resistant Plasmodium vivax malaria in Mumbai (Bombay), India.

  2000cited by this paper
• Resurgent malaria at the millennium: control strategies in crisis.

  2000cited by this paper
• In-vivo sensitivity of Plasmodium vivax isolates from Rond nia (western Amazon region, Brazil) to regimens including chloroquine and primaquine.

  2000cited by this paper
• Assessing drug sensitivity of Plasmodium vivax to halofantrine or choroquine in southern, central Vietnam using an extended 28-day in vivo test and polymerase chain reaction genotyping.

  2000cited by this paper
• An unusual case of multidrug-resistant Plasmodium vivax malaria in Mumbai (Bombay), India

  2000cited by this paper
• Chloroquine sensitivity of Plasmodium vivax in Thailand.

  1999influential reference
• Re-emerging Plasmodium vivax malaria in the Republic of Korea.

  1999cited by this paper
• Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region.

  1999cited by this paper
• In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia.

  1999cited by this paper
• Polymorphism at the merozoite surface protein-3alpha locus of Plasmodium vivax: global and local diversity.

  1999cited by this paper
• Survey of resistance in vivo to chloroquine of Plasmodium falciparum and P. vivax in North Sulawesi, Indonesia.

  1998cited by this paper
• Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia.

  1998cited by this paper
• Molecular analysis of Plasmodium vivax relapses using the MSP1 molecule as a genetic marker.

  1998cited by this paper
• Imported malaria: a retrospective study in University Hospital, Kuala Lumpur, a ten-year experience.

  1998cited by this paper
• Survey of in vivo sensitivity to chloroquine by Plasmodium falciparum and P. vivax in Lombok, Indonesia.

  1997cited by this paper
• Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels.

  1997cited by this paper
• Mefloquine Compared with Doxycycline for the Prophylaxis of Malaria in Indonesian Soldiers

  1997cited by this paper
• Whole blood chloroquine concentrations with Plasmodium vivax infection in Irian Jaya, Indonesia.

  1997cited by this paper
• Malaria: an emerging and re-emerging global plague.

  1997cited by this paper
• In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia.

  1997cited by this paper
• WR 238605, chloroquine, and their combinations as blood schizonticides against a chloroquine-resistant strain of Plasmodium vivax in Aotus monkeys.

  1997cited by this paper
• Molecular analysis of strains of Plasmodium vivax from paired primary and relapse infections.

  1996cited by this paper
• Plasmodium vivax: in vitro antiparasitic effect of cyclosporins.

  1996cited by this paper
• Survey of resistance to chloroquine of falciparum and vivax malaria in Palawan, The Philippines.

  1996influential reference
• Survey of resistance to chloroquine by Plasmodium vivax in Indonesia.

  1996cited by this paper
• Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America.

  1996cited by this paper
• Chloroquine sensitive Plasmodium falciparum and P. vivax in central Java, Indonesia.

  1996cited by this paper
• Chloroquine resistant Plasmodium vivax malaria in India

  1996cited by this paper
• Chloroquine-Resistant Plasmodium vivax Malaria in Borneo.

  1996cited by this paper
• Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria.

  1995cited by this paper
• Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine.

  1995cited by this paper
• Resurgence of malaria and drug resistance in plasmodium falciparum and plasmodium vivax species in Bombay.

  1995cited by this paper
• Clinical response and susceptibility in vitro of Plasmodium vivax to the standard regimen of chloroquine in Thailand.

  1995influential reference
• Vivax malaria resistant to chloroquine: case reports from Bombay.

  1995cited by this paper
• Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia.

  1995cited by this paper
• Combined chloroquine and primaquine resistant Plasmodium vivax malaria in a patient returning from India.

  1995cited by this paper
• Development of resistance to chloroquine by Plasmodium vivax in Myanmar.

  1995influential reference
• The efficacy of WR238605 against the blood stages of a chloroquine resistant strain of Plasmodium vivax.

  1994cited by this paper
• Chloroquine‐resistant Plasmodium vivax: how common?

  1993cited by this paper
• Canadian recommendations for the prevention and treatment of malaria among international travellers.

  1993cited by this paper
• Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma).

  1993influential reference
• Chloroquine‐resistant Plasmodium vivax: how common?

  1993cited by this paper
• Chloroquine-resistant Plasmodium vivax: how common?

  1993cited by this paper
• Chloroquine-resistant Plasmodium vivax in Papua New Guinea.

  1992cited by this paper
• Drug resistant malaria, with special reference to Thailand.

  1992cited by this paper
• The susceptibility of the Indonesian I/CDC strain of Plasmodium vivax to chloroquine.

  1992cited by this paper
• Canadian recommendations for the prevention and treatment of malaria among international travellers.

  1991cited by this paper
• Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.

  1991cited by this paper
• Chloroquine resistance in Plasmodium vivax.

  1991cited by this paper
• Auditory vestibular dysfunction after high-impact aerobics.

  1991cited by this paper
• Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia.

  1991influential reference
• Chloroquine-resistant Plasmodium vivax from Indonesia.

  1991cited by this paper
• Report of a WHO informal consultation on preclinical and clinical aspects of the use of immunomodulators in HIV infection. Geneva, 3-5 April 1989. World Health Organization Global Programme on AIDS.

  1990cited by this paper
• Plasmodium vivax resistance to chloroquine?

  1989cited by this paper
• Micro test for assaying sensitivity of Plasmodium vivax in vitro.

  1989cited by this paper
• Chloroquine-resistant Plasmodium vivax.

  1989cited by this paper
• Development of in vitro microtest for the assessment of Plasmodium vivax sensitivity to chloroquine.

  1989cited by this paper
• Chloroquine and desethylchloroquine concentrations during regular long-term malaria prophylaxis.

  1987cited by this paper
• Activity of quinoline-containing antimalarials against chloroquine-sensitive and -resistant strains of Plasmodium falciparum in vitro.

  1987cited by this paper
• [In vitro activity of chloroquine, two enantiomers of chloroquine, desethylchloroquine and pyronaridine against Plasmodium falciparum].

  1986cited by this paper
• In vitro activity of chloroquine, the two enantiomers of chloroquine, desethylchloroquine and pyronaridine against Plasmodium falciparum.

  1986cited by this paper
• A clinical trial of mefloquine in the treatment of Plasmodium vivax malaria.

  1985cited by this paper
• Chloroquine and desethylchloroquine in plasma, serum, and whole blood: problems in assay and handling of samples.

  1985cited by this paper
• Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria.

  1985cited by this paper
• A comparative clinical study of mefloquine and chloroquine in the treatment of vivax malaria.

  1985cited by this paper
• A comparative clinical study of mefloquine and chloroquine in the treatment of vivax malaria.

  1985cited by this paper
• Chloroquine resistant malaria.

  1984cited by this paper

• Efficacy of chloroquine with primaquine for uncomplicated Plasmodium vivax malaria without G6PD testing in Northwest Ethiopia: a one-arm in vivo prospective therapeutic efficacy study

  2025cites this paper
• Innovations in Antimalarial Drug Discovery: New Targets and Leads.

  2025cites this paper
• Bilayered Film Modified Glassy Carbon Electrode for the Simultaneous Determination of Paracetamol and Chloroquine in Pharmaceutical and Biological Samples

  2025cites this paper
• FocaL mass drug Administration for Plasmodium vivax Malaria Elimination (FLAME): study protocol for an open-label cluster randomized controlled trial in Peru

  2025cites this paper
• Efficacy of low-dose primaquine plus artemether-lumefantrine or dihydroartemisinin-piperaquine for radical cure of Plasmodium vivax in the Solomon Islands: a randomised clinical trial

  2025cites this paper
• FocaL mass drug administration for Plasmodium vivax malaria elimination (FLAME): study protocol for an open-label cluster randomized controlled trial in Peru

  2025cites this paper
• Therapeutic efficacy of pyronaridine-artesunate (Pyramax) in treating Plasmodium vivax malaria in the central highlands of Vietnam

  2024cites this paper
• Increased sensitivity of malaria parasites to common antimalaria drugs after the introduction of artemether-lumefantrine: Implication of policy change and implementation of more effective drugs in fight against malaria

  2024cites this paper
• Low Genetic Diversity of Plasmodium vivax Circumsporozoite Surface Protein in Clinical Isolates from Southern Thailand

  2024cites this paper
• POTENCIAL ANTIMALÁRICO DE PLANTAS MEDICINAIS: UMA REVISÃO INTEGRATIVA

  2023cites this paper
• Molecular detection of antimalarial resistance in Plasmodium vivax isolates from a tertiary care setting in Puducherry.

  2023cites this paper
• EPIDEMIC MALARIA: IS IT THREATENING TO EGYPT WITH THE TRAVELERS AND IMMIGRANTS THROUGH THE SOUTHERN BORDERS

  2023cites this paper
• A model of Plasmodium vivax malaria with delays: Mathematical analysis and numerical simulations

  2023cites this paper
• Circumsporozoite Protein from Plasmodium vivax and Its Relationship to Human Malaria

  2023cites this paper
• The First Case Series of Malaria Overlapped with COVID-19 in Iran

  2023cites this paper
• Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery—An Update

  2023cites this paper
• Treatment of uncomplicated Plasmodium vivax with chloroquine plus radical cure with primaquine without G6PDd testing is safe in Arba Minch, Ethiopia: assessment of clinical and parasitological response

  2023cites this paper
• Pharmacokinetics of chloroquine in patients with malaria by P. vivax from the Western Brazilian Amazon basin.

  2022cites this paper
• Chloroquine dosage regimen simulation for pediatric patients with coronavirus disease 2019

  2022cites this paper
• Five-Year Trend of Malaria Prevalence in Mojo Town, Central Ethiopia: Shifting Burden of the Disease and Its Implication for Malaria Elimination: A Retrospective Study

  2022cites this paper
• Genetic Diversity of Circumsporozoite Surface Protein of Plasmodium vivax from the Central Highlands, Vietnam

  2022cites this paper
• Anti‐malarial drug effects on parasite dynamics in vivax malaria

  2021cites this paper
• High proportion of genome-wide homology and increased basal pvcrt levels in Plasmodium vivax late recurrences: a chloroquine therapeutic efficacy study

  2021cites this paper
• An update on prevention of malaria in travelers

  2021cites this paper
• High Proportion of Genome-Wide Homology and Increased Pretreatment pvcrt Levels in Plasmodium vivax Late Recurrences: a Chloroquine Therapeutic Efficacy Study

  2021cites this paper
• Modelling the impact of rapid diagnostic tests on Plasmodium vivax malaria in South Korea: a cost–benefit analysis

  2021cites this paper
• In vivo efficacy of anti-malarial drugs against clinical Plasmodium vivax malaria in Ethiopia: a systematic review and meta-analysis

  2021cites this paper
• Single nucleotide polymorphism analysis of pvmdr-1 in Plasmodium vivax isolated from military personnel of Republic of Korea in 2016 and 2017

  2021cites this paper
• Efficacy Study of Chloroquine to Plasmodium vivax Malaria in Darimu and Bure Districts, Southwest Ethiopia

  2021cites this paper
• Unraveling the Complexity of Imported Malaria Infections by Amplicon Deep Sequencing

  2021cites this paper
• STANDARDIZATION OF MULTIPLEX PCR FOR THE DETECTION OF PVCRT-O, PVMDR1 RESISTANT GENES IN PLASMODIUM VIVAX AND PFCRT-O RESISTANT GENE IN PLASMODIUM FALCIPARUM

  2020cites this paper
• Malaria

  2020cites this paper
• Genetic polymorphism and natural selection of circumsporozoite protein in Myanmar Plasmodium vivax

  2020cites this paper
• Plasmodium vivax AMA1: Implications of distinct haplotypes for immune response

  2020cites this paper
• The extent of chloroquine underdosing in adult patients with malaria by Plasmodium vivax from an endemic area of the Brazilian Amazon basin

  2020influential citation
• Evolution of the Plasmodium vivax multidrug resistance 1 gene in the Greater Mekong Subregion during malaria elimination

  2020cites this paper
• Composition analysis of falsified chloroquine phosphate samples seized during the COVID-19 pandemic

  2020cites this paper
• Road Towards Development of New Antimalarial: Organelle Associated Metabolic Pathways in Plasmodium as Drug Targets and Discovery of Lead Drug Candidates

  2019cites this paper
• Efficacy of Primaquine in Preventing Short- and Long-Latency Plasmodium vivax Relapses in Nepal

  2019cites this paper
• Doses of chloroquine in the treatment of malaria by Plasmodium vivax in patients between 2 and 14 years of age from the Brazilian Amazon basin

  2019cites this paper
• Investigation of branched and linear polymers as oral delivery systems of antimalarial drugs

  2019cites this paper
• Malaria

  2019cites this paper
• Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam

  2019cites this paper
• Plasmodium vivax Malaria Viewed through the Lens of an Eradicated European Strain

  2019cites this paper
• Quimioprofilaxis del paludismo

  2019cites this paper
• Molecular detection of drug resistant malaria in Southern Thailand

  2019cites this paper
• Efficacy of TLR7 agonistic imidazoquinoline as immunochemotherapeutic agent against P. Berghei ANKA infected rodent host.

  2019cites this paper
• Therapeutic efficacy of chloroquine for treatment of Plasmodium vivax malaria cases in Guragae zone southern Central Ethiopia

  2019cites this paper
• Plasmodium vivax Biology: Insights Provided by Genomics, Transcriptomics and Proteomics

  2018cites this paper
• Evaluation of New Antimalarial Drug Combinations

  2018cites this paper
• Current scenario and future strategies to fight artemisinin resistance

  2018cites this paper
• The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis

  2018cites this paper
• Re-Emergence of Malaria in Malaysia: A Review Article

  2018cites this paper
• Advances in Malaria at MICROCON 2016

  2018cites this paper
• The prevalence of molecular markers of drug resistance in Plasmodium vivax from the border regions of Thailand in 2008 and 2014

  2018cites this paper
• Characterizing Blood-Stage Antimalarial Drug MIC Values In Vivo Using Reinfection Patterns

  2018cites this paper
• Monitoring the Response of Plasmodium vivax to Chloroquine and Uncomplicated P. falciparum to Artesunate-fansidar Antimalarials in Southeastern Iran

  2018cites this paper
• A protease cascade regulates egress of Plasmodium falciparum from the human erythrocyte

  2018cites this paper
• PvaxDB: a comprehensive structural repository of Plasmodium vivax proteome

  2018cites this paper
• The role of antimalarial quality in the emergence and transmission of resistance.

  2018cites this paper
• Antimalarial Activity of an Alkaloid Mixture Isolated from the Tender Leaves of the Nectandra membranacea (Laureaceae)

  2018cites this paper
• 296 – Antiparasitic Agents

  2018cites this paper
• Reversal of Chloroquine Resistance of Plasmodium vivax in Aotus Monkeys

  2018cites this paper
• Chloroquine and hydroxychloroquine

  2017cites this paper
• Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes

  2017cites this paper
• Domestic trends in malaria research and development in China and its global influence

  2017cites this paper
• Recent advances in use of silver nanoparticles as antimalarial agents.

  2017cites this paper
• An Overview of Currently Available Antimalarials.

  2017cites this paper
• Pengobatan Malaria Kombinasi Artemisinin (ACT) di Provinsi Papua Barat Tahun 2013

  2017influential citation
• Contemporary Views Regarding Prophylactic Third Molar Extraction among Dental Practitioners in Mumbai and Navi Mumbai City: A Cross-sectional, Questionnaire-based Survey

  2017influential citation
• Frequent Relapse of Plasmodium vivax Infection: Case Report and Literature Review

  2017cites this paper
• Analysis of Plasmodium vivax Apical Membrane Antigen-1 (PvAMA-1) Haplotypes among Iranian Isolates

  2017cites this paper
• N-Piperonyl Substitution on Aminoquinoline-Pyrimidine Hybrids : Effect on the Antimalarial Potency

  2017cites this paper
• Resistencia a las drogas antimaláricas en Bolivia

  2017influential citation
• Therapeutic efficacy of chloroquine for the treatment of Plasmodium vivax malaria among outpatients at Shawa Robit Health Care Centre, North-East Ethiopia.

  2017cites this paper
• Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial

  2017cites this paper
• 4-Aminoquinoline-ferrocenyl-chalcone conjugates: Synthesis and anti-plasmodial evaluation.

  2017cites this paper
• Time delays in the diagnosis and treatment of malaria in non-endemic countries: A systematic review.

  2017cites this paper
• Plasma metabolomics reveals membrane lipids, aspartate/asparagine and nucleotide metabolism pathway differences associated with chloroquine resistance in Plasmodium vivax malaria

  2017cites this paper
• Avaliação da atividade antimalárica e citotóxica de compostos derivados de 1,2,3- triazóis em modelo murino

  2017influential citation
• G6PD Deficiency and Antimalarial Efficacy for Uncomplicated Malaria in Bangladesh: A Prospective Observational Study

  2016cites this paper
• Chapter 6 – Antibiotic Resistance: Can Nanoparticles Tackle the Problem?

  2016cites this paper
• Clinical manifestations and molecular mechanisms in the changing paradigm of vivax malaria in India.

  2016cites this paper
• Divergent pattern of genomic variation in Plasmodium falciparum and P. vivax

  2016cites this paper
• Global Epidemiology of Plasmodium vivax

  2016influential citation
• Diagnosis and Treatment of Plasmodium vivax Malaria

  2016cites this paper
• Limited genetic diversity in the PvK12 Kelch protein in Plasmodium vivax isolates from Southeast Asia

  2016cites this paper
• Plasmodium vivaxmdr1 genotypes in isolates from successfully cured patients living in endemic and non-endemic Brazilian areas

  2016cites this paper
• Antimalarial drug resistance: An overview

  2016cites this paper
• Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study

  2016cites this paper
• A Randomized Comparison of Chloroquine versus Dihydroartemisinin–Piperaquine for the Treatment of Plasmodium vivax Infection in Vietnam

  2016cites this paper
• Computational screening and characterization of putative vaccine candidates of Plasmodium vivax

  2016cites this paper
• An HPLC method with diode array detector for the simultaneous quantification of chloroquine and desethylchloroquine in plasma and whole blood samples from Plasmodium vivax patients in Vietnam, using quinine as an internal standard

  2016influential citation
• Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border

  2016cites this paper
• UK malaria treatment guidelines 2016

  2016cites this paper
• Evaluation of the paediatric dose of chloroquine in the treatment of Plasmodium vivax malaria

  2016cites this paper
• An additional observation of Plasmodium vivax malaria infection in Duffy-negative individuals from Cameroon.

  2016cites this paper
• Antimalarial drug resistance

  2016cites this paper
• Proteomics of Plasmodium vivax malaria: new insights, progress and potential

  2016cites this paper
• Therapeutic Efficacy of Chloroquine in Plasmodium Vivax at Health Centers in Jimma Town, South-West Ethiopia

  2016cites this paper